Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/214722
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAgustí García-Navarro, Àlvar-
dc.contributor.authorMelén, Erik-
dc.contributor.authorDeMeo, Dawn L.-
dc.contributor.authorBreyer-Kohansal, Robab-
dc.contributor.authorFaner, Rosa-
dc.date.accessioned2024-07-25T11:29:41Z-
dc.date.available2024-07-25T11:29:41Z-
dc.date.issued2022-04-12-
dc.identifier.issn2213-2600-
dc.identifier.urihttp://hdl.handle.net/2445/214722-
dc.description.abstractThe traditional view of chronic obstructive pulmonary disease (COPD) as a self-inflicted disease caused by tobacco</p><p>smoking in genetically susceptible individuals has been challenged by recent research findings. COPD can instead be</p><p>understood as the potential end result of the accumulation of gene–environment interactions encountered by an</p><p>individual over the lifetime. Integration of a time axis in pathogenic models of COPD is necessary because the</p><p>biological responses to and clinical consequences of different exposures might vary according to the age of an</p><p>individual at which a given gene–environment interaction occurs, as well as to the cumulative history of previous</p><p>gene–environment interactions. Future research should aim to understand the effects of dynamic interactions</p><p>between genes (G) and the environment (E) by integrating information from basic omics (eg, genomics, epigenomics,</p><p>proteomics) and clinical omics (eg, phenomics, physiomics, radiomics) with exposures (the exposome) over time</p><p>(T)—an approach that we refer to as GETomics. In the context of this approach, we argue that COPD should be</p><p>viewed not as a single disease, but as a clinical syndrome characterised by a recognisable pattern of chronic symptoms</p><p>and structural or functional impairments due to gene–environment interactions across the lifespan that influence</p><p>normal lung development and ageing.-
dc.format.extent41 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherElsevier Ltd-
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/S2213-2600(21)00555-5-
dc.relation.ispartofThe Lancet Respiratory Medicine, 2022, vol. 10, num.5, p. 512-524-
dc.relation.urihttps://doi.org/10.1016/S2213-2600(21)00555-5-
dc.rightscc-by-nc-nd (c) Elsevier Ltd, 2022-
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.subject.classificationMalalties pulmonars obstructives cròniques-
dc.subject.classificationGenètica-
dc.subject.classificationInfluència del medi ambient en l'home-
dc.subject.classificationHàbit de fumar-
dc.subject.classificationSímptomes-
dc.subject.otherChronic obstructive pulmonary diseases-
dc.subject.otherGenetics-
dc.subject.otherEnvironmental effects on human beings-
dc.subject.otherSmoking-
dc.subject.otherSymptoms-
dc.titlePathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene-environment interactions across the lifespan-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/acceptedVersion-
dc.identifier.idgrec724830-
dc.date.updated2024-07-25T11:29:46Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Medicina)

Files in This Item:
File Description SizeFormat 
251889.pdf879.33 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons